Nanoparticle-based diagnosis and therapy.
Nanoparticles are at the leading edge of the rapidly developing field of material science in nanotechnology with many potential applications in clinical medicine and research. Due to their unique size-dependent properties nanoparticles offer the possibility to develop both new therapeutic and diagnostic tools. The ability to incorporate drugs into nanosystems displays a new paradigm in pharmacotherapy that could be used for cell-targeted drug delivery. Nontargeted nanosystems such as nanocarriers that are coated with polymers or albumin and solid lipid particles have been used to transport a large number of compounds. However, nowadays drugs can be coupled to nanocarriers that are specific for cells and/or organs. Thus, drugs that are either trapped within the carriers or deposited in subsurface oil layers could be specifically delivered to organs, tumors and cells. These strategies can be used to concentrate drugs in selected target tissues thus minimizing systemic side effects and toxicity. In addition to these therapeutic options, nanoparticle-based "molecular" imaging displays a field in which this new technology has set the stage for an evolutionary leap in diagnostic imaging. Based on the recent progress in nanobiotechnology, nanoparticles have the potential to become useful tools as therapeutic and diagnostic tools in the near future.
Groneberg
David A
DA
Department of Respiratory Medicine, Hannover School of Medicine, Carl-Neuberg-Str.1, Hannover, Germany.
Giersig
Michael
M
Welte
Tobias
T
Pison
Ulrich
U
D000818:Animals; D004337:Drug Carriers / Q000008:administration & dosage* / Q000737:chemistry*; D006801:Humans; D049329:Nanostructures; D010316:Particle Size; D019141:Respiratory System Agents / Q000008:administration & dosage*; D012140:Respiratory Tract Diseases / Q000175:diagnosis* / Q000628:therapy*
D004337:Drug Carriers; D019141:Respiratory System Agents